Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2022
Upgrades
- BTIG upgraded the previous rating for Acutus Medical Inc NASDAQ:AFIB from Neutral to Buy. In the fourth quarter, Acutus Medical showed an EPS of
$1.00 , compared to$0.89 from the year-ago quarter. The current stock performance of Acutus Medical shows a 52-week-high of$18.00 and a 52-week-low of$0.76 . Moreover, at the end of the last trading period, the closing price was at$0.80 . - For Franklin Electric Co Inc NASDAQ:FELE, Seaport Global upgraded the previous rating of Neutral to Buy. Franklin Electric earned
$0.64 in the first quarter, compared to$0.59 in the year-ago quarter. At the moment, the stock has a 52-week-high of$96.95 and a 52-week-low of$68.27 . Franklin Electric closed at$68.28 at the end of the last trading period. - B of A Securities upgraded the previous rating for Robert Half International Inc NYSE:RHI from Neutral to Buy. For the first quarter, Robert Half International had an EPS of
$1.52 , compared to year-ago quarter EPS of$0.98 . The stock has a 52-week-high of$125.77 and a 52-week-low of$83.46 . At the end of the last trading period, Robert Half International closed at$109.36 . - According to JP Morgan, the prior rating for Avery Dennison Corp NYSE:AVY was changed from Neutral to Overweight. Avery Dennison earned
$2.40 in the first quarter, compared to$2.40 in the year-ago quarter. At the moment, the stock has a 52-week-high of$229.24 and a 52-week-low of$156.51 . Avery Dennison closed at$174.22 at the end of the last trading period. - For Halliburton Co NYSE:HAL, HSBC upgraded the previous rating of Hold to Buy. For the first quarter, Halliburton had an EPS of
$0.35 , compared to year-ago quarter EPS of$0.19 . The current stock performance of Halliburton shows a 52-week-high of$42.60 and a 52-week-low of$17.82 . Moreover, at the end of the last trading period, the closing price was at$35.12 . - HSBC upgraded the previous rating for Schlumberger Ltd NYSE:SLB from Hold to Buy. For the first quarter, Schlumberger had an EPS of
$0.34 , compared to year-ago quarter EPS of$0.21 . The stock has a 52-week-high of$46.27 and a 52-week-low of$25.65 . At the end of the last trading period, Schlumberger closed at$39.54 . - For Brookfield Asset Management Inc NYSE:BAM, Credit Suisse upgraded the previous rating of Neutral to Outperform. In the fourth quarter, Brookfield Asset Mgmt showed an EPS of
$0.66 , compared to$0.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of$62.47 and a 52-week-low of$44.66 . Brookfield Asset Mgmt closed at$49.74 at the end of the last trading period. - JP Morgan upgraded the previous rating for Ecolab Inc NYSE:ECL from Neutral to Overweight. Ecolab earned
$0.82 in the first quarter, compared to$0.81 in the year-ago quarter. The stock has a 52-week-high of$238.93 and a 52-week-low of$154.85 . At the end of the last trading period, Ecolab closed at$168.47 .
See all analyst ratings upgrades.
Downgrades
- For JetBlue Airways Corp NASDAQ:JBLU, JP Morgan downgraded the previous rating of Overweight to Underweight. JetBlue Airways earned
$0.80 in the first quarter, compared to$1.48 in the year-ago quarter. At the moment, the stock has a 52-week-high of$20.89 and a 52-week-low of$11.37 . JetBlue Airways closed at$11.57 at the end of the last trading period. - B of A Securities downgraded the previous rating for Carter's Inc NYSE:CRI from Buy to Underperform. In the fourth quarter, Carter's showed an EPS of
$2.31 , compared to$2.46 from the year-ago quarter. The current stock performance of Carter's shows a 52-week-high of$116.92 and a 52-week-low of$84.41 . Moreover, at the end of the last trading period, the closing price was at$86.58 . - According to Raymond James, the prior rating for SkyWest Inc NASDAQ:SKYW was changed from Outperform to Market Perform. For the fourth quarter, SkyWest had an EPS of
$0.09 , compared to year-ago quarter EPS of$0.93 . The stock has a 52-week-high of$53.50 and a 52-week-low of$22.78 . At the end of the last trading period, SkyWest closed at$29.69 . - JP Morgan downgraded the previous rating for Bank of New York Mellon Corp NYSE:BK from Overweight to Neutral. Bank of New York Mellon earned
$0.86 in the first quarter, compared to$0.97 in the year-ago quarter. At the moment, the stock has a 52-week-high of$64.63 and a 52-week-low of$43.14 . Bank of New York Mellon closed at$43.26 at the end of the last trading period. - According to Piper Sandler, the prior rating for Capital One Financial Corp NYSE:COF was changed from Overweight to Neutral. In the first quarter, Capital One Financial showed an EPS of
$5.62 , compared to$7.03 from the year-ago quarter. The current stock performance of Capital One Financial shows a 52-week-high of$177.95 and a 52-week-low of$122.43 . Moreover, at the end of the last trading period, the closing price was at$132.23 . - For PotlatchDeltic Corp NASDAQ:PCH, RBC Capital downgraded the previous rating of Outperform to Sector Perform. For the first quarter, PotlatchDeltic had an EPS of
$2.50 , compared to year-ago quarter EPS of$1.94 . The stock has a 52-week-high of$65.67 and a 52-week-low of$48.82 . At the end of the last trading period, PotlatchDeltic closed at$53.75 .
See all analyst ratings downgrades.
Initiations
- With a Equal-Weight rating, Barclays initiated coverage on Warner Bros.Discovery Inc NASDAQ:WBD. The price target seems to have been set at
$24.00 for Warner Bros.Discovery. The stock has a 52-week-high of$27.50 and a 52-week-low of$19.63 . At the end of the last trading period, Warner Bros.Discovery closed at$19.83 . - With a Buy rating, Small Cap Consumer Research initiated coverage on Express, Inc. NYSE:EXPR. The price target seems to have been set at
$5.50 for Express. In the fourth quarter, Express showed an EPS of$0.11 , compared to$0.66 from the year-ago quarter. The current stock performance of Express shows a 52-week-high of$8.67 and a 52-week-low of$2.74 . Moreover, at the end of the last trading period, the closing price was at$3.21 . - HC Wainwright & Co. initiated coverage on Longboard Pharmaceuticals Inc NASDAQ:LBPH with a Buy rating. The price target for Longboard Pharmaceuticals is set to
$25.00 . For the first quarter, Longboard Pharmaceuticals had an EPS of$0.52 , compared to year-ago quarter EPS of$0.84 . The current stock performance of Longboard Pharmaceuticals shows a 52-week-high of$18.50 and a 52-week-low of$3.90 . Moreover, at the end of the last trading period, the closing price was at$4.80 . - RBC Capital initiated coverage on AECOM NYSE:ACM with an Outperform rating. The price target for AECOM is set to
$91.00 . In the first quarter, AECOM showed an EPS of$0.89 , compared to$0.62 from the year-ago quarter. At the moment, the stock has a 52-week-high of$79.97 and a 52-week-low of$58.36 . AECOM closed at$71.17 at the end of the last trading period. - With an Outperform rating, RBC Capital initiated coverage on Jacobs Engineering Group Inc NYSE:J. The price target seems to have been set at
$173.00 for Jacobs Engineering Group. Jacobs Engineering Group earned$1.56 in the first quarter, compared to$1.41 in the year-ago quarter. The current stock performance of Jacobs Engineering Group shows a 52-week-high of$150.32 and a 52-week-low of$114.11 . Moreover, at the end of the last trading period, the closing price was at$137.83 . - Goldman Sachs initiated coverage on Organon & Co NYSE:OGN with a Buy rating. The price target for Organon is set to
$40.00 . The current stock performance of Organon shows a 52-week-high of$39.48 and a 52-week-low of$27.25 . Moreover, at the end of the last trading period, the closing price was at$31.66 . - With a Buy rating, Goldman Sachs initiated coverage on Royalty Pharma PLC NASDAQ:RPRX. The price target seems to have been set at
$56.00 for Royalty Pharma. For the fourth quarter, Royalty Pharma had an EPS of$0.80 , compared to year-ago quarter EPS of$0.27 . The current stock performance of Royalty Pharma shows a 52-week-high of$47.10 and a 52-week-low of$34.86 . Moreover, at the end of the last trading period, the closing price was at$41.83 . - Goldman Sachs initiated coverage on WalkMe Ltd NASDAQ:WKME with a Buy rating. The price target for WalkMe is set to
$23.00 . The current stock performance of WalkMe shows a 52-week-high of$34.42 and a 52-week-low of$11.50 . Moreover, at the end of the last trading period, the closing price was at$14.92 . - With a Buy rating, Goldman Sachs initiated coverage on Appian Corp NASDAQ:APPN. The price target seems to have been set at
$70.00 for Appian. In the fourth quarter, Appian showed an EPS of$0.16 , compared to$0.03 from the year-ago quarter. The current stock performance of Appian shows a 52-week-high of$149.82 and a 52-week-low of$46.85 . Moreover, at the end of the last trading period, the closing price was at$48.37 . - With a Neutral rating, Goldman Sachs initiated coverage on Vor Biopharma Inc NASDAQ:VOR. The price target seems to have been set at
$6.00 for Vor Biopharma. For the fourth quarter, Vor Biopharma had an EPS of$0.49 , compared to year-ago quarter EPS of$55.10 . At the moment, the stock has a 52-week-high of$31.20 and a 52-week-low of$5.02 . Vor Biopharma closed at$5.60 at the end of the last trading period. - UBS initiated coverage on Cazoo Group Ltd NYSE:CZOO with a Neutral rating. The price target for Cazoo Gr is set to
$2.60 . The stock has a 52-week-high of$10.13 and a 52-week-low of$1.99 . At the end of the last trading period, Cazoo Gr closed at$1.99 . - With a Buy rating, Goldman Sachs initiated coverage on Insmed Inc NASDAQ:INSM. The price target seems to have been set at
$56.00 for Insmed. For the fourth quarter, Insmed had an EPS of$0.95 , compared to year-ago quarter EPS of$1.00 . The current stock performance of Insmed shows a 52-week-high of$36.97 and a 52-week-low of$20.02 . Moreover, at the end of the last trading period, the closing price was at$22.22 .
See all analyst ratings initiations.